🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Chemed Corporation boosts share repurchase program by $300 million

Published 06/11/2023, 16:00
© Reuters.
CHE
-

Chemed Corporation (NYSE: NYSE:CHE), a Cincinnati-based company operating VITAS Healthcare and Roto-Rooter, has sanctioned an additional $300 million for its share repurchase program. The decision, approved by the Board of Directors, was announced today, Monday.

The increase in the buyback program is to be financed through operational cash flows and the company's revolving credit facility. This move underscores the firm's confidence in its financial health and commitment to return value to shareholders.

VITAS Healthcare and Roto-Rooter, Chemed's subsidiaries, are national leaders in their respective fields. VITAS specializes in end-of-life hospice care, while Roto-Rooter is renowned for its plumbing and drain cleaning services.

In relation to this announcement, Chemed's representative, Michael D. Witzeman, issued forward-looking statements concerning the company's future performance. However, he also cautioned investors about the inherent risk tied to such projections. The discrepancies between these predictions and actual results may be significant, serving as a reminder for investors to exercise due diligence when making decisions based on forward-looking statements.

InvestingPro Insights

Chemed Corporation (NYSE: CHE) continues to demonstrate financial strength, as evidenced by the InvestingPro data. With a market capitalization of $8810M and a P/E ratio of 36.39, the company is well-positioned in the market. Over the last twelve months as of Q3 2023, the company has seen a revenue growth of 4.5%, signaling a positive trend in its financial performance.

InvestingPro Tips highlights that Chemed has a history of strong earnings which have allowed for consistent dividend payments. The company has raised its dividend for 14 consecutive years and has maintained dividend payments for a notable 53 years. This consistency is a testament to the company's financial stability and commitment to shareholder value. Additionally, the company's stock is trading near its 52-week high, indicating a strong market performance.

These insights, along with over 20 additional InvestingPro Tips, are available for those looking to make informed investment decisions. They provide a comprehensive view of the company's financial health and market performance, offering investors a valuable tool for their decision-making process.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.